These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 7034429)
1. Serum antibodies against Escherichia coli and Proteus mirabilis after different types of operations. Bergman B; Holm SE; Holmlund D; Kaijser B Acta Chir Scand; 1981; 147(2):93-7. PubMed ID: 7034429 [TBL] [Abstract][Full Text] [Related]
2. Conduit urinary diversion and urinary-tract infection. II. Raised serum antibody titers against Escherichia coli and Proteus mirabilis in relation to bacteriologic findings. Bergman B; Kaijser B; Nilson AE Scand J Urol Nephrol; 1979; 13(1):71-7. PubMed ID: 368977 [TBL] [Abstract][Full Text] [Related]
3. Conduiturinary diversion and urinary-tract infection. I. Serum antibody titers against Escherichia coli and Proteus mirabilis in relation to urographic findings. Bergman B; Kaijser K; Nilson AE Scand J Urol Nephrol; 1979; 13(1):65-70. PubMed ID: 368976 [TBL] [Abstract][Full Text] [Related]
4. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis. Newkirk MM; Goldbach-Mansky R; Senior BW; Klippel J; Schumacher HR; El-Gabalawy HS Rheumatology (Oxford); 2005 Nov; 44(11):1433-41. PubMed ID: 16091399 [TBL] [Abstract][Full Text] [Related]
5. Elevation in anti-Proteus antibodies in patients with rheumatoid arthritis from Bermuda and England. Subair H; Tiwana H; Fielder M; Binder A; Cunningham K; Ebringer A; Wilson C; Hudson MJ J Rheumatol; 1995 Oct; 22(10):1825-8. PubMed ID: 8991977 [TBL] [Abstract][Full Text] [Related]
6. Detection of anti-Proteus antibodies in sera of patients with rheumatoid arthritis. Gautam V; Sehgal R; Paramjeet SG; Arora DR Indian J Pathol Microbiol; 2003 Jan; 46(1):137-41. PubMed ID: 15027757 [TBL] [Abstract][Full Text] [Related]
7. [Demonstration of antibody-coated bacteria in the urine of pregnant women]. Budde E; Herrmann C; Scholz B; Naumann G; Nimmich W Zentralbl Gynakol; 1977; 99(13):769-75. PubMed ID: 331754 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of urinary tract infections with SolcoUrovac]. Litschgi M Geburtshilfe Frauenheilkd; 1987 Feb; 47(2):107-10. PubMed ID: 3106132 [TBL] [Abstract][Full Text] [Related]
9. Bacteriuria in patients with a continent ileal reservoir for urinary diversion does not regularly require antibiotic treatment. Akerlund S; Campanello M; Kaijser B; Jonsson O Br J Urol; 1994 Aug; 74(2):177-81. PubMed ID: 7921934 [TBL] [Abstract][Full Text] [Related]
10. [Significance of antibody titers in recurrent urinary tract infection in children (author's transl)]. Daschner F Med Klin; 1976 Sep; 71(37):1491-6. PubMed ID: 822268 [TBL] [Abstract][Full Text] [Related]
11. Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis. Tani Y; Tiwana H; Hukuda S; Nishioka J; Fielder M; Wilson C; Bansal S; Ebringer A J Rheumatol; 1997 Jan; 24(1):109-14. PubMed ID: 9002020 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of growth of Proteus mirabilis and Escherichia coli in urine in response to fasting and vegetarian diet. Kjeldsen-Kragh J; Kvaavik E; Bottolfs M; Lingaas E APMIS; 1995 Nov; 103(11):818-22. PubMed ID: 8546847 [TBL] [Abstract][Full Text] [Related]
13. [Serodiagnosis and the immunological aspects of Proteus infection. IV. Serum antibody level and the pathomorphological and bacteriological indices in experimental mixed and monoinfections of the urinary tract]. Bidnenko SI; Barshteĭn IuA; Anisimova IuI; Open'ko LV Zh Mikrobiol Epidemiol Immunobiol; 1982; (11):108-13. PubMed ID: 6760626 [TBL] [Abstract][Full Text] [Related]
14. [Specific immune response in asymptomatic bacteriuria in pregnancy]. Airò R; Carusillo MG; Rivetti I Boll Ist Sieroter Milan; 1980; 59(6):625-31. PubMed ID: 7016137 [TBL] [Abstract][Full Text] [Related]
15. [Urinary tract infections in chronic alcoholics. Studies with E. coli and B. proteus antigens]. Pawliszyn W; Teleśnicki S Pol Tyg Lek; 1974 Nov; 29(44):1879-81. PubMed ID: 4610532 [No Abstract] [Full Text] [Related]
16. Serum immunoglobulin M concentrations following bowel resection in chronic inflammatory bowel disease. Soltis RD; Wilson ID Gastroenterology; 1975 Oct; 69(4):885-92. PubMed ID: 1100468 [TBL] [Abstract][Full Text] [Related]
17. Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis. Mobley HL; Island MD; Massad G Kidney Int Suppl; 1994 Nov; 47():S129-36. PubMed ID: 7869662 [TBL] [Abstract][Full Text] [Related]
18. [Protective effect of coli-proteus vaccine in an experimental animal model]. Bĕlohlávek S; Konícková L Cesk Farm; 1980 May; 29(3-4):95-9. PubMed ID: 6996844 [No Abstract] [Full Text] [Related]
19. Decrease in anti-Proteus mirabilis but not anti-Escherichia coli antibody levels in rheumatoid arthritis patients treated with fasting and a one year vegetarian diet. Kjeldsen-Kragh J; Rashid T; Dybwad A; Sioud M; Haugen M; Førre O; Ebringer A Ann Rheum Dis; 1995 Mar; 54(3):221-4. PubMed ID: 7748020 [TBL] [Abstract][Full Text] [Related]
20. Serotyping of clinical isolates belonging to Proteus mirabilis serogroup O36 and structural elucidation of the O36-antigen polysaccharide. Arabski M; Grabowski S; Konieczna I; Kaca W; Kondakova AN; Perepelov AV; Senchenkova SN; Shashkov AS; Knirel YA FEMS Immunol Med Microbiol; 2008 Aug; 53(3):395-403. PubMed ID: 18625011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]